Hubert Tseng

Hubert Tseng is a Senior Principal Scientist in gRED Research Biology at Genentech, focusing on the mechanisms behind CAR-T efficacy through single-cell and multi-omics approaches. Hubert previously held positions at organizations such as Poseida Therapeutics, Inc., Targazyme, and Nano3D Biosciences, where they contributed to the development of innovative therapies and drug discovery techniques. Hubert served as an Adjunct Assistant Professor at The University of Texas Health Science Center at Houston, collaborating on precision oncology assay development. Hubert earned a Bachelor of Science degree in Engineering Mechanics and Applied Mathematics & Statistics from The Johns Hopkins University and a PhD in Bioengineering from Rice University.